Paper63801
Small-bowel abnormalities in multiple sclerosis.
Lange LS and 1 other. Lancet, 1976. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Small-bowel abnormalities in multiple sclerosis. Papers, record 63801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/63801
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Jejunum | Major topic |
| Multiple Sclerosis | Major topic |
| Adult | |
| Aged | |
| Atrophy | |
| Female | |
| Humans | |
| Intestinal Mucosa | |
| Male | |
| Microscopy, Electron | |
| Middle Aged |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41229423 | Intestinal mucosal alterations parallel central demyelination and remyelination: insights into the gut-brain axis in the cuprizone model of multiple sclerosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41229423 | PubMed |
| 41169367 | The link between gut microbiota and multiple sclerosis from the perspective of barrier function. | Front Immunol | 2025 | https://conductscience.org/library/papers/41169367 | PubMed |
| 39974366 | Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients. | Front Neurol | 2025 | https://conductscience.org/library/papers/39974366 | PubMed |
| 39237437 | Life history of a brain autoreactive T cell: From thymus through intestine to blood-brain barrier and brain lesion. | Neurotherapeutics | 2024 | https://conductscience.org/library/papers/39237437 | PubMed |
| 38008941 | Intestinal Barrier Function and Neurodegenerative Disease. | CNS Neurol Disord Drug Targets | 2024 | https://conductscience.org/library/papers/38008941 | PubMed |
| 29860380 | The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. | Brain | 2018 | https://conductscience.org/library/papers/29860380 | PubMed |
| 24381825 | Multiple sclerosis. | Glob Adv Health Med | 2013 | https://conductscience.org/library/papers/24381825 | PubMed |
| 23026980 | The influence of nutritional factors on the prognosis of multiple sclerosis. | Nat Rev Neurol | 2012 | https://conductscience.org/library/papers/23026980 | PubMed |
| 12521563 | Current Complementary and Alternative Therapies for Multiple Sclerosis. | Curr Treat Options Neurol | 2003 | https://conductscience.org/library/papers/12521563 | PubMed |
| 7130993 | Zinc and copper in multiple sclerosis. | J Neurol Neurosurg Psychiatry | 1982 | https://conductscience.org/library/papers/7130993 | PubMed |
| 577190 | Multiple sclerosis and milk. | Can Med Assoc J | 1977 | https://conductscience.org/library/papers/577190 | PubMed |
| 448378 | Morphological and biochemical findings in jejunal biopsies from patients with multiple sclerosis. | J Neurol Neurosurg Psychiatry | 1979 | https://conductscience.org/library/papers/448378 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/63801
GET https://conductscience.org/api/papers/v1/63801/authors